Showing results (11-20 of 255) with videos related to
Sort By:
Pageof 26
The Oncologist|October 8, 2003
PET scans in the staging of lymphoma: current statusJonathan W Friedberg, Vaseem ChengaziCurrent Hematologic Malignancy Reports|April 29, 2010
Beyond rituximab: The future of monoclonal antibodies in B-cell non-Hodgkin lymphomaManzurul A Sikder, Jonathan W FriedbergHematology/Oncology Clinics of North America|October 29, 2008
Diffuse large B-cell lymphomaJonathan W Friedberg, Richard I FisherFuture Oncology (London, England)|January 15, 2021
Axicabtagene ciloleucel and brexucabtagene autoleucel in relapsed and refractory diffuse large B-cell and mantle cell lymphomasPatrick M Reagan, Jonathan W FriedbergSeminars in Hematology|April 3, 2008
Non-myeloablative radioimmunotherapy for non-Hodgkin's lymphomaJulia Schaefer-Cutillo, Jonathan W FriedbergExpert Review of Anticancer Therapy|January 30, 2004
Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphomaJonathan W Friedberg, Richard I FisherCurrent Treatment Options in Oncology|August 19, 2006
Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphomaJonathan W Friedberg, Arnold S FreedmanHematology/Oncology Clinics of North America|August 31, 2020
Key Clinical and Translational Research Questions to Address Unmet Needs in Mantle Cell LymphomaThomas D Rodgers, Jonathan W FriedbergOncology (Williston Park, N.Y.)|May 19, 2017
Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New DirectionsPatrick M Reagan, Jonathan W FriedbergJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2023
Classic Hodgkin Lymphoma in Adolescents and Young AdultsKara M Kelly, Jonathan W FriedbergPageof 26